Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Denis

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
European Urology|January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinomaK H Kurth, F M Debruyne, R R Hall, et al.
The Journal of Urology|March 1, 1992
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary GroupT A Splinter, H I Scher, L Denis, et al.
NPJ Parkinson'S Disease|May 7, 2026
High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's diseaseCyntia Tremblay, Laura Pshevorskiy, Rosalie J Cottez, et al.
Cancer|December 15, 1993
Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853). European Organization for Research and Treatment of Cancer--Genitourinary GroupF Keuppens, P Whelan, J L Carneiro de Moura, et al.
The Urologic Clinics of North America|February 1, 1991
Total androgen ablation: European experience. The EORTC GU GroupL Denis, P Smith, J L Carneiro de Moura, et al.
Neurobiology of Disease|March 26, 2023
Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis modelMarie Rieux, Melanie Alpaugh, Shireen Salem, et al.
Neurobiology of Disease|September 18, 2023
Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24]Marie Rieux, Melanie Alpaugh, Shireen Salem, et al.
Progress in Clinical and Biological Research|January 1, 1987
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancerL Denis, F Keuppens, C Mahler, et al.
European Urology|January 1, 1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU GroupL Denis, P H Smith, J L De Moura, et al.
The Journal of Urology|October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinomaF M Debruyne, L Denis, G Lunglmayer, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
European Urology|January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinomaK H Kurth, F M Debruyne, R R Hall, et al.
The Journal of Urology|March 1, 1992
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary GroupT A Splinter, H I Scher, L Denis, et al.
NPJ Parkinson'S Disease|May 7, 2026
High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's diseaseCyntia Tremblay, Laura Pshevorskiy, Rosalie J Cottez, et al.
Cancer|December 15, 1993
Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853). European Organization for Research and Treatment of Cancer--Genitourinary GroupF Keuppens, P Whelan, J L Carneiro de Moura, et al.
The Urologic Clinics of North America|February 1, 1991
Total androgen ablation: European experience. The EORTC GU GroupL Denis, P Smith, J L Carneiro de Moura, et al.
Neurobiology of Disease|March 26, 2023
Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis modelMarie Rieux, Melanie Alpaugh, Shireen Salem, et al.
Neurobiology of Disease|September 18, 2023
Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24]Marie Rieux, Melanie Alpaugh, Shireen Salem, et al.
Progress in Clinical and Biological Research|January 1, 1987
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancerL Denis, F Keuppens, C Mahler, et al.
European Urology|January 1, 1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU GroupL Denis, P H Smith, J L De Moura, et al.
The Journal of Urology|October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinomaF M Debruyne, L Denis, G Lunglmayer, et al.
Pageof 31